LeMaitre Vascular Inc (LMAT)
Cash conversion cycle
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 343.64 | 287.52 | 323.30 | 317.26 | 367.99 |
| Days of sales outstanding (DSO) | days | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — |
| Cash conversion cycle | days | 343.64 | 287.52 | 323.30 | 317.26 | 367.99 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 343.64 + — – —
= 343.64
The cash conversion cycle of LeMaitre Vascular Inc has shown fluctuations over the years. As of December 31, 2020, the company had a cash conversion cycle of 367.99 days, indicating a lengthy period between the company's cash outflows for production and the receipt of cash from sales.
Over the following years, there was a slight improvement in the efficiency of the company's cash conversion cycle. By December 31, 2021, the cycle had decreased to 317.26 days, showing a reduction in the time it takes for the company to convert its investments in inventory and other resources into cash inflows from sales.
Subsequently, on December 31, 2022, the cash conversion cycle further reduced to 323.30 days, but then saw a more significant improvement to 287.52 days by December 31, 2023. This indicates that the company was managing its working capital more effectively, resulting in a quicker turnover of its operating cycle components.
However, by December 31, 2024, the cash conversion cycle increased to 343.64 days compared to the previous year, suggesting that there may have been challenges in managing the company's working capital efficiency.
Overall, despite some fluctuations, LeMaitre Vascular Inc has shown a trend of improving its cash conversion cycle, indicating better management of its working capital and potentially enhanced operational efficiency in recent years.
Peer comparison
Dec 31, 2024